152 related articles for article (PubMed ID: 37408677)
1. Proton Therapy for Unresectable and Medically Inoperable Locally Advanced Pancreatic Cancer: Results From a Multi-Institutional Prospective Registry.
Eckstein J; Choi JI; Lozano A; Ohri N; Press R; Hasan S; Kabarriti R; Chang J; Urbanic J; Durci M; Mohammed N; Stevens C; Tsai H; Apisarnthanarax S; Regine W; Vargas C; Nichols R; Herman J; Simone CB; Chhabra A
Adv Radiat Oncol; 2023; 8(5):101250. PubMed ID: 37408677
[TBL] [Abstract][Full Text] [Related]
2. Reirradiation With Proton Therapy for Recurrent Malignancies of the Esophagus and Gastroesophageal Junction: Results of the Proton Collaborative Group Multi-Institutional Prospective Registry Trial.
Hotca A; Sindhu KK; Lehrer EJ; Hartsell WF; Vargas C; Tsai HK; Chang JH; Apisarnthanarax S; Nichols RC; Chhabra AM; Hasan S; Press RH; Lazarev S; Hajj C; Kabarriti R; Rule WG; Simone CB; Choi JI
Adv Radiat Oncol; 2024 May; 9(5):101459. PubMed ID: 38596455
[TBL] [Abstract][Full Text] [Related]
3. Proton Beam Reirradiation for Recurrent Head and Neck Cancer: Multi-institutional Report on Feasibility and Early Outcomes.
Romesser PB; Cahlon O; Scher ED; Hug EB; Sine K; DeSelm C; Fox JL; Mah D; Garg MK; Han-Chih Chang J; Lee NY
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):386-395. PubMed ID: 27084656
[TBL] [Abstract][Full Text] [Related]
4. Proton Beam Radiotherapy and Concurrent Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer: Final Results of a Phase 2 Study.
Chang JY; Verma V; Li M; Zhang W; Komaki R; Lu C; Allen PK; Liao Z; Welsh J; Lin SH; Gomez D; Jeter M; O'Reilly M; Zhu RX; Zhang X; Li H; Mohan R; Heymach JV; Vaporciyan AA; Hahn S; Cox JD
JAMA Oncol; 2017 Aug; 3(8):e172032. PubMed ID: 28727865
[TBL] [Abstract][Full Text] [Related]
5. Clinical Outcomes in Patients with Recurrent Glioblastoma Treated with Proton Beam Therapy Reirradiation: Analysis of the Multi-Institutional Proton Collaborative Group Registry.
Saeed AM; Khairnar R; Sharma AM; Larson GL; Tsai HK; Wang CJ; Halasz LM; Chinnaiyan P; Vargas CE; Mishra MV
Adv Radiat Oncol; 2020; 5(5):978-983. PubMed ID: 33083661
[TBL] [Abstract][Full Text] [Related]
6. Association of Ablative Radiation Therapy With Survival Among Patients With Inoperable Pancreatic Cancer.
Reyngold M; O'Reilly EM; Varghese AM; Fiasconaro M; Zinovoy M; Romesser PB; Wu A; Hajj C; Cuaron JJ; Tuli R; Hilal L; Khalil D; Park W; Yorke ED; Zhang Z; Yu KH; Crane CH
JAMA Oncol; 2021 May; 7(5):735-738. PubMed ID: 33704353
[TBL] [Abstract][Full Text] [Related]
7. Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma.
Herman JM; Chang DT; Goodman KA; Dholakia AS; Raman SP; Hacker-Prietz A; Iacobuzio-Donahue CA; Griffith ME; Pawlik TM; Pai JS; O'Reilly E; Fisher GA; Wild AT; Rosati LM; Zheng L; Wolfgang CL; Laheru DA; Columbo LA; Sugar EA; Koong AC
Cancer; 2015 Apr; 121(7):1128-37. PubMed ID: 25538019
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes and toxicity of proton beam therapy for advanced cholangiocarcinoma.
Makita C; Nakamura T; Takada A; Takayama K; Suzuki M; Ishikawa Y; Azami Y; Kato T; Tsukiyama I; Kikuchi Y; Hareyama M; Murakami M; Fuwa N; Hata M; Inoue T
Radiat Oncol; 2014 Jan; 9():26. PubMed ID: 24422711
[TBL] [Abstract][Full Text] [Related]
9. A Multi-Institutional Experience of Proton Beam Therapy for Sinonasal Tumors.
Yu NY; Gamez ME; Hartsell WF; Tsai HK; Laramore GE; Larson GL; Simone CB; Rossi C; Katz SR; Buras MR; Golafshar MA; Vargas CE; Patel SH
Adv Radiat Oncol; 2019; 4(4):689-698. PubMed ID: 31673662
[TBL] [Abstract][Full Text] [Related]
10. Duodenal toxicity after fractionated chemoradiation for unresectable pancreatic cancer.
Kelly P; Das P; Pinnix CC; Beddar S; Briere T; Pham M; Krishnan S; Delclos ME; Crane CH
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):e143-9. PubMed ID: 23200173
[TBL] [Abstract][Full Text] [Related]
11. Hypofractionated sequential radiotherapy boost: a promising strategy in inoperable locally advanced pancreatic cancer patients.
Mattiucci GC; Boldrini L; Nardangeli A; D'Aviero A; Buwenge M; Cellini F; Deodato F; Dinapoli N; Frascino V; Macchia G; Morganti AG; Valentini V
J Cancer Res Clin Oncol; 2021 Mar; 147(3):661-667. PubMed ID: 33001271
[TBL] [Abstract][Full Text] [Related]
12. Multi-institutional Study of Carbon-ion Radiotherapy for Locally Advanced Pancreatic Cancer: Japan Carbon-ion Radiation Oncology Study Group (J-CROS) Study 1403 Pancreas.
Kawashiro S; Yamada S; Okamoto M; Ohno T; Nakano T; Shinoto M; Shioyama Y; Nemoto K; Isozaki Y; Tsuji H; Kamada T
Int J Radiat Oncol Biol Phys; 2018 Aug; 101(5):1212-1221. PubMed ID: 29907490
[TBL] [Abstract][Full Text] [Related]
13. Clinical Outcomes of Patients With Recurrent Lung Cancer Reirradiated With Proton Therapy on the Proton Collaborative Group and University of Florida Proton Therapy Institute Prospective Registry Studies.
Badiyan SN; Rutenberg MS; Hoppe BS; Mohindra P; Larson G; Hartsell WF; Tsai H; Zeng J; Rengan R; Glass E; Katz S; Vargas C; Feigenberg SJ; Simone CB
Pract Radiat Oncol; 2019; 9(4):280-288. PubMed ID: 30802618
[TBL] [Abstract][Full Text] [Related]
14. Reirradiation for Locoregional Recurrent Breast Cancer.
Fattahi S; Ahmed SK; Park SS; Petersen IA; Shumway DA; Stish BJ; Yan ES; Remmes NB; Mutter RW; Corbin KS
Adv Radiat Oncol; 2021; 6(1):100640. PubMed ID: 33506143
[TBL] [Abstract][Full Text] [Related]
15. Proton Beam Therapy for Bronchogenic Adenoid Cystic Carcinoma: Dosimetry, Toxicities, and Outcomes.
Verma V; Lin L; Simone CB
Int J Part Ther; 2018; 4(4):1-9. PubMed ID: 31773012
[TBL] [Abstract][Full Text] [Related]
16. Proton Beam Therapy for Children With Neuroblastoma: Experiences From the Prospective KiProReg Registry.
Jazmati D; Butzer S; Hero B; Ahmad Khalil D; Merta J; Bäumer C; Plum G; Fuchs J; Koerber F; Steinmeier T; Peters S; Doyen J; Thole T; Schmidt M; Blase C; Tippelt S; Eggert A; Schwarz R; Simon T; Timmermann B
Front Oncol; 2020; 10():617506. PubMed ID: 33552991
[TBL] [Abstract][Full Text] [Related]
17. Pathologic complete response (pCR) rates and outcomes after neoadjuvant chemoradiotherapy with proton or photon radiation for adenocarcinomas of the esophagus and gastroesophageal junction.
DeCesaris CM; Berger M; Choi JI; Carr SR; Burrows WM; Regine WF; Simone CB; Molitoris JK
J Gastrointest Oncol; 2020 Aug; 11(4):663-673. PubMed ID: 32953150
[TBL] [Abstract][Full Text] [Related]
18. Re-irradiation with stereotactic body radiation therapy as a novel treatment option for isolated local recurrence of pancreatic cancer after multimodality therapy: experience from two institutions.
Wild AT; Hiniker SM; Chang DT; Tran PT; Khashab MA; Limaye MR; Laheru DA; Le DT; Kumar R; Pai JS; Hargens B; Sharabi AB; Shin EJ; Zheng L; Pawlik TM; Wolfgang CL; Koong AC; Herman JM
J Gastrointest Oncol; 2013 Dec; 4(4):343-51. PubMed ID: 24294505
[TBL] [Abstract][Full Text] [Related]
19. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
20. Dose-escalated Hypofractionated Intensity-modulated Radiation Therapy With Concurrent Chemotherapy for Inoperable or Unresectable Non-Small Cell Lung Cancer.
Kim JO; Chu KP; Fairchild A; Ghosh S; Butts C; Chu Q; Gabos Z; Joy AA; Nijjar T; Robinson DM; Sangha R; Scrimger R; Smylie M; Yee D; Roa WH
Am J Clin Oncol; 2017 Jun; 40(3):294-299. PubMed ID: 25333733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]